Deactivation of Circulating Tumor Cells (CTCs) in the Bloodstream by Electrostatic Stimulation of the Peripheral Blood
Copyright © Targeted News Service 2026
2026-11-10
ALEXANDRIA, Virginia, Nov. 10 -- MANDEGAR ADVANCED MEDICAL TECHNOLOGIES DEVELOPMENT COMPANY, , Iran has been assigned a patent (No. US 12788861 B2, initially filed Nov. 13, 2024) developed by five inventors Mohammad Abdolahad, Tehran, Iran; Mohammad Reza Ghaderinia, Tehran, Iran; Mohammad Ali Khayamian, Tehran, Iran; Hamed Abadijoo, Tehran, Iran; and Shahriar shalileh, Tehran, Iran, for "Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the periph . . .
